Patents by Inventor Chris MacGregor

Chris MacGregor has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SOLID DOSE FORMULATIONS FOR NEEDLE-FREE DELIVERY
    Publication number: 20250288526
    Abstract: The present disclosure relates to solid dose formulations for needle-free delivery comprising 0.01 to 60 (w/w) of one or more therapeutic agent and/or prophylactic agent; and 40.0% to 99.99% (w/w) of dextran. The invention further concerns methods of producing a solid dose formulation tablet and application its particular medical uses, in particular as a vaccine.
    Type: Application
    Filed: May 29, 2025
    Publication date: September 18, 2025
    Applicant: AVAXZIPEN LIMITED
    Inventors: David Andrew Grant, Chris MacGregor
  • Solid dose formulations for needle-free delivery
    Patent number: 12364665
    Abstract: The present disclosure relates to solid dose formulations for needle-free delivery comprising 0.01 to 60 (w/w) of one or more therapeutic agent and/or prophylactic agent; and 40.0% to 99.99% (w/w) of dextran. The invention further concerns methods of producing a solid dose formulation tablet and application its particular medical uses, in particular as a vaccine.
    Type: Grant
    Filed: June 25, 2020
    Date of Patent: July 22, 2025
    Assignee: AVAXZIPEN LIMITED
    Inventors: David Andrew Grant, Chris MacGregor
  • SOLID DOSE FORMULATIONS FOR NEEDLE-FREE DELIVERY
    Publication number: 20220249379
    Abstract: The present disclosure relates to solid dose formulations for needle-free delivery comprising 0.01 to 60 (w/w) of one or more therapeutic agent and/or prophylactic agent; and 40.0% to 99.99% (w/w) of dextran. The invention further concerns methods of producing a solid dose formulation tablet and application its particular medical uses, in particular as a vaccine.
    Type: Application
    Filed: June 25, 2020
    Publication date: August 11, 2022
    Applicant: Enesi Pharma Limited
    Inventors: David Andrew Grant, Chris MacGregor